BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37729705)

  • 1. Chicken dendritic cell-targeting nanobodies mediated improved protective effects against H9N2 influenza virus challenge in a homologous sequential immunization study.
    Jia F; Sun C; Ge C; Wang Z; Zhang T; Zhang M; Wang W; Tian Y; He Y; Yang G; Yang W; Shi C; Wang J; Huang H; Jiang Y; Wang C
    Vet Microbiol; 2023 Oct; 285():109875. PubMed ID: 37729705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homologous Sequential Immunization Using Salmonella Oral Administration Followed by an Intranasal Boost with Ferritin-Based Nanoparticles Enhanced the Humoral Immune Response against H1N1 Influenza Virus.
    Wang Z; Zhang T; Jia F; Ge C; He Y; Tian Y; Wang W; Yang G; Huang H; Wang J; Shi C; Yang W; Cao X; Zeng Y; Wang N; Qian A; Wang C; Jiang Y
    Microbiol Spectr; 2023 Jun; 11(3):e0010223. PubMed ID: 37154735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with recombinant 4 × M2e.HSP70c fusion protein as a universal vaccine candidate enhances both humoral and cell-mediated immune responses and decreases viral shedding against experimental challenge of H9N2 influenza in chickens.
    Dabaghian M; Latify AM; Tebianian M; Nili H; Ranjbar AR; Mirjalili A; Mohammadi M; Banihashemi R; Ebrahimi SM
    Vet Microbiol; 2014 Nov; 174(1-2):116-26. PubMed ID: 25293397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza virus-like particles harboring H9N2 HA and NA proteins induce a protective immune response in chicken.
    Li X; Ju H; Liu J; Yang D; Qi X; Yang X; Qiu Y; Zheng J; Ge F; Zhou J
    Influenza Other Respir Viruses; 2017 Nov; 11(6):518-524. PubMed ID: 28752641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination with recombinant Lactococcus lactis expressing HA1-IgY Fc fusion protein provides protective mucosal immunity against H9N2 avian influenza virus in chickens.
    Zhang R; Xu T; Li Z; Li L; Li C; Li X; Wang Z; Wang S; Wang X; Zhang H
    Virol J; 2023 Apr; 20(1):76. PubMed ID: 37085816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cell-targeted recombinantLactobacilli induce DC activation and elicit specific immune responses against G57 genotype of avian H9N2 influenza virus infection.
    Sun Y; Qian J; Xu X; Tang Y; Xu W; Yang W; Jiang Y; Yang G; Ding Z; Cong Y; Wang C
    Vet Microbiol; 2018 Sep; 223():9-20. PubMed ID: 30173758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral immunization with an attenuated
    Hajam IA; Kirthika P; Hewawaduge C; Jawalagatti V; Park S; Senevirathne A; Lee JH
    Avian Pathol; 2020 Oct; 49(5):486-495. PubMed ID: 32483989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of chickens against H9N2 avian influenza virus challenge with recombinant Lactobacillus plantarum expressing conserved antigens.
    Yang WT; Yang GL; Shi SH; Liu YY; Huang HB; Jiang YL; Wang JZ; Shi CW; Jing YB; Wang CF
    Appl Microbiol Biotechnol; 2017 Jun; 101(11):4593-4603. PubMed ID: 28353000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimeric Newcastle Disease Virus-like Particles Containing DC-Binding Peptide-Fused Haemagglutinin Protect Chickens from Virulent Newcastle Disease Virus and H9N2 Avian Influenza Virus Challenge.
    Xu X; Qian J; Qin L; Li J; Xue C; Ding J; Wang W; Ding W; Yin R; Jin N; Ding Z
    Virol Sin; 2020 Aug; 35(4):455-467. PubMed ID: 32274680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced cross-lineage protection induced by recombinant H9N2 avian influenza virus inactivated vaccine.
    Wang Z; Li Z; Su X; Qiao Y; Fan W; Li H; Shi B; Qin T; Chen S; Peng D; Liu X
    Vaccine; 2019 Mar; 37(13):1736-1742. PubMed ID: 30797637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single oral immunization of an attenuated Salmonella Gallinarium formulation consisting of equal quantities of strains secreting H9N2 hemagglutinin-HA1, HA2, and M2eCD154 induces significant protection against H9N2 and partial protection against Salmonella Gallinarium challenge in chickens.
    Senevirathne A; Hewawaduge C; Park S; Jawalagatti V; Kim C; Seo BJ; Lee E; Lee JH
    Vet Immunol Immunopathol; 2021 Oct; 240():110318. PubMed ID: 34479105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel recombinant attenuated Newcastle disease virus expressing H9 subtype hemagglutinin protected chickens from challenge by genotype VII virulent Newcastle disease virus and H9N2 avian influenza virus.
    Xu X; Xue C; Liu X; Li J; Fei Y; Liu Z; Mu J; Bi Y; Qian J; Yin R; Ding Z
    Vet Microbiol; 2019 Jan; 228():173-180. PubMed ID: 30593364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing immunogenicity and protective efficacy of inactivated avian influenza H9N2vaccine with recombinant chicken IFN-α in chicken.
    Gan L; Tian Y; Zhao Y; Shan XQ; Zhou W; Xia BB; Chen J; Wang ML; Zhao J
    Vet Microbiol; 2019 Jul; 234():77-82. PubMed ID: 31213275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral administration of live attenuated Salmonella enterica serovar Typhimurium expressing chicken interferon-α alleviates clinical signs caused by respiratory infection with avian influenza virus H9N2.
    Rahman MM; Uyangaa E; Han YW; Kim SB; Kim JH; Choi JY; Yoo DJ; Hong JT; Han SB; Kim B; Kim K; Eo SK
    Vet Microbiol; 2011 Dec; 154(1-2):140-51. PubMed ID: 21764226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel "prime and pull" strategy mediated by the combination of two dendritic cell-targeting designs induced protective lung tissue-resident memory T cells against H1N1 influenza virus challenge.
    Wang Z; He Y; Wang W; Tian Y; Ge C; Jia F; Zhang T; Zhang G; Wang M; Gong J; Huang H; Wang J; Shi C; Yang W; Cao X; Zeng Y; Wang N; Qian A; Jiang Y; Yang G; Wang C
    J Nanobiotechnology; 2023 Dec; 21(1):479. PubMed ID: 38093320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Priming with a DNA vaccine delivered by attenuated Salmonella typhimurium and boosting with a killed vaccine confers protection of chickens against infection with the H9 subtype of avian influenza virus.
    Pan Z; Zhang X; Geng S; Cheng N; Sun L; Liu B; Huang J; Jiao X
    Vaccine; 2009 Feb; 27(7):1018-23. PubMed ID: 19103246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of Th1-biased protective immunity against avian influenza H9N2 virus via oral co-administration of attenuated Salmonella enterica serovar Typhimurium expressing chicken interferon-α and interleukin-18 along with an inactivated vaccine.
    Rahman MM; Uyangaa E; Han YW; Kim SB; Kim JH; Choi JY; Eo SK
    BMC Vet Res; 2012 Jul; 8():105. PubMed ID: 22776696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A two dose immunization with an inactivated reassortant H5N2 virus protects chickens against lethal challenge with homologous 2.3.2.1 clade and heterologous 2.2 clade highly pathogenic avian influenza H5N1 viruses.
    Bhat S; Sood R; Shukla S; Khandia R; Pateriya AK; Kumar N; Singh VK; Kalaiyarasu S; Kumar M; Bhatia S
    Vet Microbiol; 2018 Apr; 217():149-157. PubMed ID: 29615248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses of chickens inoculated with a recombinant fowlpox vaccine coexpressing HA of H9N2 avain influenza virus and chicken IL-18.
    Chen HY; Shang YH; Yao HX; Cui BA; Zhang HY; Wang ZX; Wang YD; Chao AJ; Duan TY
    Antiviral Res; 2011 Jul; 91(1):50-6. PubMed ID: 21549153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal Immunization with a Recombinant Avian Paramyxovirus Serotypes 2 Vector-Based Vaccine Induces Protection against H9N2 Avian Influenza in Chicken.
    Yang W; Dai J; Liu J; Guo M; Liu X; Hu S; Gu M; Hu J; Hu Z; Gao R; Liu K; Chen Y; Liu X; Wang X
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.